参考资料:
[1] Genentech’s Subcutaneous Ocrevus One-Year Data Demonstrates Near-Complete Suppression of Clinical Relapses and Brain Lesions in Patients With Progressive and Relapsing Forms of MS. Retrieved April 17, 2024, from https://www.businesswire.com/news/home/20240416088195/en